Related Experiment Video
Updated: Oct 16, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Human epididymis protein 4: a novel predictor of ischemic cardiomyopathy
Yi Tang1, Yinzhen Wang1, Xiaoping Xu2
1Department of Cardiology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Clinical Medicine Research Center of Heart Failure of Hunan Province, Hunan Normal University, Changsha, 410005, China.
Insights
Human epididymis protein 4 (HE4) is a significant predictor of adverse cardiovascular events in patients with ischemic cardiomyopathy (ICM). Higher HE4 levels indicate an increased risk of cardiovascular death and heart failure rehospitalization.
Area of Science:
- Cardiology
- Biomarkers
- Clinical Research
Background:
- The prognostic significance of human epididymis protein 4 (HE4) in ischemic cardiomyopathy (ICM) remains undetermined.
- HE4 is a glycoprotein with potential roles in various physiological and pathological processes.
Purpose of the Study:
- To investigate the prognostic value of serum HE4 levels in patients diagnosed with ICM.
- To determine if HE4 can predict cardiovascular death and heart failure-related hospitalizations in this patient cohort.
Main Methods:
- Prospective enrollment of 103 patients with ICM.
- Baseline and follow-up serum HE4 measurements.
- Analysis of cardiovascular death and heart failure-related hospitalization as endpoints.
Main Results:
- Serum HE4 levels were significantly higher in patients who experienced cardiovascular events compared to those who did not (P < 0.001).
- HE4 was identified as an independent predictor of events (HR: 1.003, P = 0.002), alongside age.
- Patients with HE4 levels > 100.2 pmol/L had a 3.372-fold higher risk of events (P < 0.001).
Conclusions:
- Human epididymis protein 4 (HE4) serves as an independent prognostic marker in patients with ICM.
- Elevated HE4 levels are associated with an increased risk of cardiovascular death and heart failure rehospitalization.
Background:
The prognostic value of human epididymis protein 4 (HE4) in patients with ischemic cardiomyopathy (ICM) is unknown.
Methods:
A total of 103 patients with ICM were prospectively enrolled in this study from Hunan Provincial People's Hospital between February 2019 and June 2019. All patients were tested for HE4 levels at baseline and follow-up. Endpoints of the study included cardiovascular death and heart failure-related hospitalization.
Results:
A total of 96 patients with ICM were included for analysis. After a mean follow-up period of 263 (153-313) days, cardiovascular events were observed in 45 patients. Serum HE4 levels in patients with events were significantly higher than those in patients without events [188.70 (113.35-326.82) pmol/L versus 92.90 (61.50-123.20) pmol/L, P < 0.001]. Multivariate Cox regression analysis revealed that HE4 [χ2: 9.602, hazard ratio (HR): 1.003, 95% confidence interval (CI): 1.001-1.005, P = 0.002] and age [χ2: 4.55, HR: 1.044, 95% CI: 1.003-1.085, P = 0.033] were independent predictors of events. After adjusting for age and sex, the risk of events in patients with HE4 > 100.2 pmol/L was higher than that in patients with HE4 ≤ 100.2 pmol/L [HR: 3.372, 95% CI: 1.409-8.065, P < 0.001].
Conclusion:
HE4 is an independent predictor of cardiovascular death and heart failure-related rehospitalization in patients with ICM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction

